11月12日中源协和涨10.00%，银河医药混合A基金重仓该股

中金财经

Nov 12

　　证券之星消息，11月12日中源协和(600645)涨10.00%，收盘报28.61元，换手率6.66%，成交量31.14万手，成交额8.57亿元。该股为干细胞、基因编辑、CAR-T疗法、基因测序、体外诊断、精准医疗、医疗器械、创新药、医药、化妆品概念热股。11月12日的资金流向数据方面，主力资金净流入1.94亿元，占总成交额22.65%，游资资金净流出1.01亿元，占总成交额11.77%，散户资金净流出9320.26万元，占总成交额10.88%。融资融券方面近5日融资净流入3754.95万，融资余额增加；融券净流入4.13万，融券余额增加。重仓中源协和的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为5.03亿元，最新净值0.6087(11月11日)，较上一交易日上涨0.28%，近一年上涨9.4%。该公募基金现任基金经理为方伟。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-21.19%；银河医药混合A的前十大重仓股如下：为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2582264883"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582264883\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582264883?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/ http://caiji.3g.cnfol.com/colect/202511/12/20251112899235.png?op=imageView2&mode=2&width=256&height=256&quality=70&format=png","is_english":false,"pubTime":"2025-11-12 16:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582264883","market":"hk","top_or_hot":-1,"title":"11月12日中源协和涨10.00%，银河医药混合A基金重仓该股","media":"中金财经","content":"<html><body><p>　　证券之星消息，11月12日<a href=\"https://laohu8.com/S/600645\">中源协和</a>(600645)涨10.00%，收盘报28.61元，换手率6.66%，成交量31.14万手，成交额8.57亿元。该股为干细胞、基因编辑、CAR-T疗法、基因测序、体外诊断、精准医疗、医疗器械、创新药、医药、化妆品概念热股。11月12日的资金流向数据方面，主力资金净流入1.94亿元，占总成交额22.65%，游资资金净流出1.01亿元，占总成交额11.77%，散户资金净流出9320.26万元，占总成交额10.88%。融资融券方面近5日融资净流入3754.95万，融资余额增加；融券净流入4.13万，融券余额增加。重仓中源协和的公募基金请见下表：    根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为<a href=\"https://laohu8.com/S/000806\">银河</a>基金的银河医药混合A。银河医药混合A目前规模为5.03亿元，最新净值0.6087(11月11日)，较上一交易日上涨0.28%，近一年上涨9.4%。该公募基金现任基金经理为方伟。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-21.19%；银河医药混合A的前十大重仓股如下：    为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。 </p></body></html>","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>11月12日中源协和涨10.00%，银河医药混合A基金重仓该股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n11月12日中源协和涨10.00%，银河医药混合A基金重仓该股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-12 16:49 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushiyaowen/20251112/31788698.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，11月12日中源协和(600645)涨10.00%，收盘报28.61元，换手率6.66%，成交量31.14万手，成交额8.57亿元。该股为干细胞、基因编辑、CAR-T疗法、基因测序、体外诊断、精准医疗、医疗器械、创新药、医药、化妆品概念热股。11月12日的资金流向数据方面，主力资金净流入1.94亿元，占总成交额22.65%，游资资金净流出1.01亿元，占总成交额11.77%，散户资金...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushiyaowen/20251112/31788698.shtml\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251112/31788698.shtml","article_id":"2582264883","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/ http://caiji.3g.cnfol.com/colect/202511/12/20251112899235.png?op=imageView2&mode=2&width=256&height=256&quality=70&format=png"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582264883","pubTimestamp":1762937359,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"证券之星消息，11月12日中源协和涨10.00%，收盘报28.61元，换手率6.66%，成交量31.14万手，成交额8.57亿元。重仓中源协和的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为5.03亿元，最新净值0.6087，较上一交易日上涨0.28%，近一年上涨9.4%。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","600645":"中源协和","BK1515":"抗疫概念","BK1161":"生物科技","BK0188":"融资融券","BK1574":"生物医药B类股","BK0239":"医药制造","BK0046":"生物疫苗","BK0042":"基因检测","09939":"开拓药业-B","BK0216":"研究试验"},"translate_title":"On November 12, Zhongyuan Xiehe rose 10.00%, and Galaxy Pharmaceutical Mixed A Fund held a heavy position in the stock","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1.5,"600645":1.5,"09939":1.5},"content_text":"证券之星消息，11月12日中源协和(600645)涨10.00%，收盘报28.61元，换手率6.66%，成交量31.14万手，成交额8.57亿元。该股为干细胞、基因编辑、CAR-T疗法、基因测序、体外诊断、精准医疗、医疗器械、创新药、医药、化妆品概念热股。11月12日的资金流向数据方面，主力资金净流入1.94亿元，占总成交额22.65%，游资资金净流出1.01亿元，占总成交额11.77%，散户资金净流出9320.26万元，占总成交额10.88%。融资融券方面近5日融资净流入3754.95万，融资余额增加；融券净流入4.13万，融券余额增加。重仓中源协和的公募基金请见下表：    根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为5.03亿元，最新净值0.6087(11月11日)，较上一交易日上涨0.28%，近一年上涨9.4%。该公募基金现任基金经理为方伟。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-21.19%；银河医药混合A的前十大重仓股如下：    为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}